secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001558370-24-008535
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio receives second Nasdaq deficiency notice; stock bid below $1 for 31 days
--------------------------------------------------------------------------------

- Nasdaq notified Mustang Bio on May 16, 2024 that bid price closed below $1 for 31 consecutive business days.
- Company has 180 days, until November 12, 2024, to regain compliance by closing at $1.00 or more for 10+ days.
- Prior stockholders' equity deficiency: Nasdaq granted extension through September 9, 2024 to regain compliance.
- If not cured, Mustang may seek a second grace period or request a hearing to avoid delisting.
- No decision yet on reverse stock split or other remedy; delisting risk remains if compliance is not achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000155837024008535/0001558370-24-008535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000155837024008535/tmb-20240516x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer